Concepts (319)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Hip | 77 | 2022 | 821 | 8.000 |
Why?
|
| Arthroplasty, Replacement, Knee | 54 | 2023 | 625 | 6.640 |
Why?
|
| Prosthesis-Related Infections | 29 | 2023 | 186 | 5.240 |
Why?
|
| Hip Prosthesis | 45 | 2022 | 552 | 5.120 |
Why?
|
| Prosthesis Failure | 39 | 2021 | 536 | 3.900 |
Why?
|
| Acetabulum | 17 | 2020 | 231 | 3.220 |
Why?
|
| Reoperation | 65 | 2023 | 917 | 3.000 |
Why?
|
| Knee Prosthesis | 21 | 2023 | 222 | 2.650 |
Why?
|
| Femur | 22 | 2019 | 382 | 2.540 |
Why?
|
| Prosthesis Design | 26 | 2022 | 498 | 2.460 |
Why?
|
| Arthritis, Infectious | 7 | 2023 | 53 | 1.880 |
Why?
|
| Knee Joint | 22 | 2022 | 746 | 1.640 |
Why?
|
| Aged | 75 | 2023 | 9277 | 1.570 |
Why?
|
| Humans | 129 | 2023 | 28436 | 1.500 |
Why?
|
| Osteolysis | 8 | 2015 | 144 | 1.500 |
Why?
|
| Anti-Bacterial Agents | 9 | 2023 | 383 | 1.460 |
Why?
|
| Middle Aged | 69 | 2022 | 9269 | 1.360 |
Why?
|
| Bone Cements | 7 | 2020 | 90 | 1.330 |
Why?
|
| Postoperative Complications | 17 | 2018 | 932 | 1.320 |
Why?
|
| Retrospective Studies | 48 | 2023 | 3612 | 1.300 |
Why?
|
| Joint Diseases | 6 | 2021 | 113 | 1.300 |
Why?
|
| Male | 79 | 2022 | 15291 | 1.260 |
Why?
|
| Pain, Postoperative | 8 | 2022 | 316 | 1.250 |
Why?
|
| Female | 76 | 2022 | 15730 | 1.210 |
Why?
|
| Aged, 80 and over | 46 | 2022 | 4857 | 1.080 |
Why?
|
| Hip Joint | 14 | 2020 | 545 | 1.050 |
Why?
|
| Radiography | 21 | 2019 | 640 | 0.990 |
Why?
|
| Periprosthetic Fractures | 6 | 2019 | 26 | 0.960 |
Why?
|
| Tibia | 10 | 2021 | 244 | 0.910 |
Why?
|
| Bone Resorption | 5 | 2014 | 85 | 0.850 |
Why?
|
| Vancomycin | 3 | 2018 | 52 | 0.830 |
Why?
|
| Joint Instability | 8 | 2018 | 394 | 0.820 |
Why?
|
| Hip Dislocation | 9 | 2016 | 70 | 0.810 |
Why?
|
| Pelvic Bones | 3 | 2012 | 18 | 0.740 |
Why?
|
| Treatment Outcome | 34 | 2023 | 3615 | 0.730 |
Why?
|
| Gentamicins | 2 | 2018 | 16 | 0.730 |
Why?
|
| Tobramycin | 2 | 2018 | 10 | 0.730 |
Why?
|
| Leg Length Inequality | 3 | 2016 | 9 | 0.720 |
Why?
|
| Synovial Fluid | 11 | 2017 | 95 | 0.710 |
Why?
|
| Tantalum | 8 | 2018 | 26 | 0.710 |
Why?
|
| Arthroplasty, Replacement | 2 | 2016 | 153 | 0.680 |
Why?
|
| Follow-Up Studies | 20 | 2019 | 1859 | 0.630 |
Why?
|
| Adult | 39 | 2022 | 8107 | 0.620 |
Why?
|
| Decision Support Techniques | 2 | 2011 | 52 | 0.610 |
Why?
|
| Radiostereometric Analysis | 1 | 2018 | 7 | 0.600 |
Why?
|
| Anti-Infective Agents, Local | 2 | 2016 | 46 | 0.600 |
Why?
|
| Incidence | 9 | 2018 | 773 | 0.600 |
Why?
|
| Population Surveillance | 2 | 2018 | 110 | 0.590 |
Why?
|
| Surgical Wound Infection | 2 | 2016 | 88 | 0.570 |
Why?
|
| Acute Kidney Injury | 1 | 2018 | 47 | 0.570 |
Why?
|
| Osseointegration | 7 | 2016 | 67 | 0.560 |
Why?
|
| Osteotomy | 8 | 2014 | 171 | 0.560 |
Why?
|
| Device Removal | 7 | 2013 | 92 | 0.550 |
Why?
|
| Mupirocin | 1 | 2016 | 17 | 0.520 |
Why?
|
| Bupivacaine | 1 | 2016 | 46 | 0.510 |
Why?
|
| Perioperative Care | 4 | 2017 | 45 | 0.500 |
Why?
|
| Anesthetics, Local | 1 | 2016 | 81 | 0.490 |
Why?
|
| Metal-on-Metal Joint Prostheses | 2 | 2015 | 51 | 0.490 |
Why?
|
| Osteoarthritis, Hip | 4 | 2015 | 107 | 0.480 |
Why?
|
| Risk Factors | 12 | 2019 | 2408 | 0.480 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2016 | 116 | 0.470 |
Why?
|
| Femur Head | 2 | 2006 | 67 | 0.470 |
Why?
|
| Metals | 4 | 2015 | 152 | 0.460 |
Why?
|
| Prospective Studies | 9 | 2019 | 1809 | 0.440 |
Why?
|
| Decision Trees | 2 | 2011 | 14 | 0.440 |
Why?
|
| Medical Device Recalls | 1 | 2013 | 1 | 0.440 |
Why?
|
| Dexamethasone | 1 | 2013 | 35 | 0.420 |
Why?
|
| Polymethyl Methacrylate | 2 | 2011 | 12 | 0.420 |
Why?
|
| Bacteremia | 1 | 2013 | 101 | 0.410 |
Why?
|
| Coated Materials, Biocompatible | 3 | 2014 | 40 | 0.400 |
Why?
|
| Osteoarthritis, Knee | 5 | 2021 | 366 | 0.400 |
Why?
|
| Ketamine | 2 | 2022 | 25 | 0.400 |
Why?
|
| Algorithms | 9 | 2022 | 377 | 0.400 |
Why?
|
| Poisoning | 1 | 2012 | 2 | 0.400 |
Why?
|
| Fractures, Bone | 3 | 2013 | 75 | 0.390 |
Why?
|
| Antirheumatic Agents | 3 | 2017 | 86 | 0.390 |
Why?
|
| Patient Readmission | 1 | 2013 | 133 | 0.390 |
Why?
|
| Skin Diseases | 1 | 2012 | 26 | 0.380 |
Why?
|
| Prostheses and Implants | 2 | 2010 | 161 | 0.370 |
Why?
|
| United States | 14 | 2022 | 2201 | 0.360 |
Why?
|
| Transplantation, Homologous | 7 | 2015 | 281 | 0.350 |
Why?
|
| Patient Satisfaction | 3 | 2019 | 328 | 0.350 |
Why?
|
| Orthopedic Surgeons | 2 | 2022 | 27 | 0.350 |
Why?
|
| Biomechanical Phenomena | 8 | 2021 | 645 | 0.340 |
Why?
|
| Iliac Artery | 1 | 2009 | 5 | 0.330 |
Why?
|
| Demography | 3 | 2019 | 73 | 0.330 |
Why?
|
| Foreign-Body Migration | 1 | 2009 | 19 | 0.320 |
Why?
|
| Elective Surgical Procedures | 3 | 2018 | 39 | 0.310 |
Why?
|
| Quality of Life | 2 | 2011 | 661 | 0.310 |
Why?
|
| Recovery of Function | 8 | 2016 | 300 | 0.300 |
Why?
|
| Bone Transplantation | 4 | 2012 | 209 | 0.290 |
Why?
|
| Rheumatology | 3 | 2017 | 85 | 0.290 |
Why?
|
| Time Factors | 10 | 2020 | 1491 | 0.290 |
Why?
|
| Patient Discharge | 1 | 2009 | 168 | 0.280 |
Why?
|
| Surgeons | 4 | 2022 | 89 | 0.280 |
Why?
|
| Arthroplasty | 3 | 2022 | 150 | 0.270 |
Why?
|
| Therapeutic Irrigation | 4 | 2019 | 56 | 0.260 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2011 | 318 | 0.260 |
Why?
|
| C-Reactive Protein | 7 | 2016 | 104 | 0.240 |
Why?
|
| Salmonella arizonae | 1 | 2005 | 1 | 0.240 |
Why?
|
| Cementation | 1 | 2005 | 33 | 0.240 |
Why?
|
| Occupational Diseases | 1 | 2005 | 21 | 0.240 |
Why?
|
| Equipment Failure Analysis | 3 | 2015 | 108 | 0.230 |
Why?
|
| Risk Assessment | 8 | 2018 | 677 | 0.220 |
Why?
|
| Physical Examination | 4 | 2019 | 118 | 0.220 |
Why?
|
| Debridement | 3 | 2013 | 102 | 0.220 |
Why?
|
| Feasibility Studies | 2 | 2018 | 232 | 0.220 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 2003 | 3 | 0.210 |
Why?
|
| Blood Sedimentation | 8 | 2016 | 54 | 0.210 |
Why?
|
| Clinical Competence | 2 | 2019 | 249 | 0.210 |
Why?
|
| Cohort Studies | 7 | 2020 | 1926 | 0.200 |
Why?
|
| Pain Measurement | 4 | 2016 | 472 | 0.200 |
Why?
|
| Preoperative Care | 5 | 2016 | 125 | 0.200 |
Why?
|
| Anesthesia, Conduction | 1 | 2022 | 34 | 0.200 |
Why?
|
| Medicare | 4 | 2013 | 121 | 0.200 |
Why?
|
| Logistic Models | 3 | 2018 | 396 | 0.200 |
Why?
|
| Biocompatible Materials | 3 | 2017 | 95 | 0.200 |
Why?
|
| Femoral Neck Fractures | 1 | 2022 | 10 | 0.190 |
Why?
|
| Foreign Bodies | 1 | 2002 | 30 | 0.190 |
Why?
|
| Porosity | 5 | 2017 | 61 | 0.190 |
Why?
|
| Femoral Fractures | 2 | 2019 | 33 | 0.190 |
Why?
|
| Hemiarthroplasty | 1 | 2022 | 35 | 0.190 |
Why?
|
| Case-Control Studies | 2 | 2018 | 594 | 0.190 |
Why?
|
| Postoperative Period | 3 | 2018 | 331 | 0.180 |
Why?
|
| Analgesics, Opioid | 2 | 2022 | 216 | 0.180 |
Why?
|
| Odds Ratio | 2 | 2019 | 268 | 0.180 |
Why?
|
| Leukocyte Count | 7 | 2016 | 66 | 0.180 |
Why?
|
| Bone Nails | 1 | 2020 | 14 | 0.180 |
Why?
|
| Prescriptions | 1 | 2020 | 18 | 0.170 |
Why?
|
| Arthrodesis | 1 | 2020 | 42 | 0.170 |
Why?
|
| Glucocorticoids | 2 | 2017 | 70 | 0.170 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2019 | 9 | 0.170 |
Why?
|
| Tertiary Care Centers | 1 | 2020 | 67 | 0.170 |
Why?
|
| Rheumatic Diseases | 2 | 2017 | 53 | 0.170 |
Why?
|
| Illinois | 2 | 2018 | 246 | 0.160 |
Why?
|
| Disease Management | 3 | 2017 | 113 | 0.160 |
Why?
|
| Polyethylene | 2 | 2021 | 132 | 0.160 |
Why?
|
| Treatment Failure | 1 | 2019 | 163 | 0.160 |
Why?
|
| Mobile Applications | 1 | 2019 | 32 | 0.160 |
Why?
|
| Physician Assistants | 1 | 2019 | 16 | 0.150 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 372 | 0.150 |
Why?
|
| Microspheres | 1 | 2018 | 24 | 0.150 |
Why?
|
| Creatinine | 1 | 2018 | 53 | 0.150 |
Why?
|
| Absorption, Physiological | 1 | 2017 | 2 | 0.150 |
Why?
|
| Body Mass Index | 5 | 2020 | 465 | 0.150 |
Why?
|
| Knee | 1 | 2017 | 45 | 0.140 |
Why?
|
| Range of Motion, Articular | 7 | 2020 | 704 | 0.140 |
Why?
|
| Leukocytes | 1 | 2017 | 38 | 0.140 |
Why?
|
| Tendons | 2 | 2012 | 224 | 0.140 |
Why?
|
| Prosthesis Fitting | 3 | 2011 | 21 | 0.140 |
Why?
|
| Nurse Practitioners | 1 | 2019 | 109 | 0.140 |
Why?
|
| Regression Analysis | 1 | 2017 | 266 | 0.140 |
Why?
|
| Registries | 3 | 2022 | 188 | 0.140 |
Why?
|
| Allografts | 2 | 2015 | 218 | 0.140 |
Why?
|
| Povidone-Iodine | 2 | 2019 | 5 | 0.130 |
Why?
|
| Self Concept | 1 | 2016 | 42 | 0.130 |
Why?
|
| Methicillin | 1 | 2016 | 7 | 0.130 |
Why?
|
| Liposomes | 1 | 2016 | 13 | 0.130 |
Why?
|
| Biological Products | 1 | 2017 | 45 | 0.130 |
Why?
|
| Administration, Intranasal | 1 | 2016 | 27 | 0.130 |
Why?
|
| Methicillin Resistance | 1 | 2016 | 25 | 0.130 |
Why?
|
| Orthopedic Procedures | 3 | 2019 | 312 | 0.130 |
Why?
|
| Kidney | 1 | 2017 | 175 | 0.130 |
Why?
|
| Nasal Cavity | 1 | 2016 | 32 | 0.130 |
Why?
|
| Staphylococcal Infections | 2 | 2016 | 158 | 0.130 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 140 | 0.130 |
Why?
|
| Staphylococcus aureus | 1 | 2016 | 68 | 0.130 |
Why?
|
| Chlorhexidine | 1 | 2016 | 57 | 0.130 |
Why?
|
| Injections, Intra-Articular | 1 | 2016 | 91 | 0.130 |
Why?
|
| Patella | 2 | 2015 | 72 | 0.130 |
Why?
|
| Cell Count | 1 | 2015 | 79 | 0.120 |
Why?
|
| Sleep Wake Disorders | 1 | 2017 | 130 | 0.120 |
Why?
|
| Prevalence | 3 | 2013 | 468 | 0.120 |
Why?
|
| Ceramics | 1 | 2015 | 22 | 0.120 |
Why?
|
| Foreign-Body Reaction | 1 | 2015 | 29 | 0.120 |
Why?
|
| Sensitivity and Specificity | 6 | 2015 | 517 | 0.120 |
Why?
|
| Nerve Block | 1 | 2016 | 67 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 319 | 0.120 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2018 | 179 | 0.120 |
Why?
|
| Intraoperative Complications | 2 | 2013 | 67 | 0.110 |
Why?
|
| Bone Diseases | 2 | 2005 | 25 | 0.110 |
Why?
|
| Length of Stay | 2 | 2013 | 329 | 0.110 |
Why?
|
| Observer Variation | 1 | 2014 | 102 | 0.110 |
Why?
|
| Sleep | 1 | 2017 | 355 | 0.110 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2013 | 16 | 0.110 |
Why?
|
| Awards and Prizes | 1 | 2013 | 21 | 0.110 |
Why?
|
| Insurance, Health | 1 | 2013 | 23 | 0.110 |
Why?
|
| Decision Making | 2 | 2006 | 226 | 0.110 |
Why?
|
| Random Allocation | 1 | 2013 | 129 | 0.110 |
Why?
|
| Medicaid | 1 | 2013 | 38 | 0.110 |
Why?
|
| Surveys and Questionnaires | 4 | 2019 | 1216 | 0.100 |
Why?
|
| Bone Remodeling | 1 | 2013 | 49 | 0.100 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 80 | 0.100 |
Why?
|
| Tibial Fractures | 1 | 2012 | 7 | 0.100 |
Why?
|
| ROC Curve | 4 | 2016 | 144 | 0.100 |
Why?
|
| Heavy Metal Poisoning | 1 | 2012 | 1 | 0.100 |
Why?
|
| Braces | 1 | 2012 | 23 | 0.100 |
Why?
|
| Reimbursement Mechanisms | 1 | 2012 | 12 | 0.100 |
Why?
|
| Serologic Tests | 1 | 2011 | 9 | 0.090 |
Why?
|
| Predictive Value of Tests | 4 | 2014 | 492 | 0.090 |
Why?
|
| Suction | 3 | 2015 | 40 | 0.080 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2017 | 263 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2012 | 185 | 0.080 |
Why?
|
| Corrosion | 3 | 2015 | 134 | 0.080 |
Why?
|
| Infection Control | 1 | 2011 | 166 | 0.080 |
Why?
|
| Pain Management | 2 | 2022 | 147 | 0.080 |
Why?
|
| Vascular Surgical Procedures | 1 | 2009 | 26 | 0.080 |
Why?
|
| Sepsis | 1 | 2010 | 144 | 0.080 |
Why?
|
| Anesthesia | 1 | 2009 | 31 | 0.080 |
Why?
|
| Ambulatory Care | 1 | 2009 | 74 | 0.080 |
Why?
|
| Preoperative Period | 2 | 2020 | 81 | 0.080 |
Why?
|
| Hip Fractures | 1 | 2008 | 26 | 0.070 |
Why?
|
| Body Weight | 2 | 2019 | 144 | 0.070 |
Why?
|
| Arthritis, Juvenile | 2 | 2017 | 7 | 0.070 |
Why?
|
| Piperidines | 2 | 2017 | 12 | 0.070 |
Why?
|
| Pyrimidines | 2 | 2017 | 22 | 0.070 |
Why?
|
| Arthritis, Psoriatic | 2 | 2017 | 14 | 0.070 |
Why?
|
| Pyrroles | 2 | 2017 | 24 | 0.070 |
Why?
|
| Linear Models | 2 | 2018 | 251 | 0.070 |
Why?
|
| Spondylitis, Ankylosing | 2 | 2017 | 21 | 0.070 |
Why?
|
| Biomarkers | 3 | 2017 | 596 | 0.070 |
Why?
|
| Patient Care Team | 1 | 2009 | 141 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2020 | 441 | 0.070 |
Why?
|
| Age Distribution | 2 | 2005 | 89 | 0.070 |
Why?
|
| Sex Distribution | 2 | 2005 | 82 | 0.070 |
Why?
|
| Guided Tissue Regeneration | 1 | 2006 | 11 | 0.070 |
Why?
|
| Joint Dislocations | 2 | 2018 | 55 | 0.070 |
Why?
|
| Chicago | 3 | 2018 | 946 | 0.070 |
Why?
|
| Southeastern United States | 1 | 2006 | 14 | 0.070 |
Why?
|
| Surface Properties | 1 | 2006 | 140 | 0.070 |
Why?
|
| Contraindications | 1 | 2006 | 33 | 0.060 |
Why?
|
| Neutrophils | 2 | 2017 | 110 | 0.060 |
Why?
|
| Ankle Injuries | 1 | 2005 | 9 | 0.060 |
Why?
|
| Salmonella Infections | 1 | 2005 | 1 | 0.060 |
Why?
|
| Markov Chains | 1 | 2005 | 32 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2014 | 988 | 0.060 |
Why?
|
| Osteogenesis | 1 | 2005 | 110 | 0.060 |
Why?
|
| Animal Husbandry | 1 | 2005 | 8 | 0.060 |
Why?
|
| Graft Survival | 1 | 2005 | 102 | 0.060 |
Why?
|
| Swine | 1 | 2005 | 81 | 0.060 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2017 | 192 | 0.060 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2005 | 122 | 0.060 |
Why?
|
| Health Status Indicators | 1 | 2005 | 75 | 0.060 |
Why?
|
| Databases, Factual | 2 | 2022 | 358 | 0.060 |
Why?
|
| Chromium | 2 | 2015 | 91 | 0.050 |
Why?
|
| Animals | 3 | 2007 | 3780 | 0.050 |
Why?
|
| Cobalt | 2 | 2015 | 113 | 0.050 |
Why?
|
| Titanium | 2 | 2015 | 181 | 0.050 |
Why?
|
| Hospitalization | 1 | 2005 | 323 | 0.050 |
Why?
|
| Tendon Injuries | 1 | 2005 | 212 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 146 | 0.050 |
Why?
|
| Polyethylenes | 1 | 2002 | 39 | 0.050 |
Why?
|
| Young Adult | 3 | 2014 | 2069 | 0.050 |
Why?
|
| Analgesics | 1 | 2022 | 81 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2022 | 134 | 0.050 |
Why?
|
| Comorbidity | 1 | 2003 | 500 | 0.050 |
Why?
|
| Machine Learning | 1 | 2022 | 75 | 0.050 |
Why?
|
| Social Class | 1 | 2021 | 67 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2003 | 688 | 0.040 |
Why?
|
| Statistics, Nonparametric | 2 | 2012 | 128 | 0.040 |
Why?
|
| Recurrence | 2 | 2011 | 322 | 0.040 |
Why?
|
| Benzodiazepines | 1 | 2020 | 48 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2020 | 111 | 0.040 |
Why?
|
| Arthritis | 1 | 2020 | 53 | 0.040 |
Why?
|
| Antidepressive Agents | 1 | 2020 | 98 | 0.040 |
Why?
|
| Survivorship | 1 | 2019 | 20 | 0.040 |
Why?
|
| Fracture Fixation, Internal | 1 | 2019 | 62 | 0.040 |
Why?
|
| Osteoarthritis | 1 | 2003 | 328 | 0.040 |
Why?
|
| Patient Selection | 2 | 2012 | 206 | 0.040 |
Why?
|
| Pain | 1 | 2022 | 405 | 0.040 |
Why?
|
| Patient Preference | 1 | 2019 | 33 | 0.040 |
Why?
|
| Forecasting | 1 | 2018 | 103 | 0.040 |
Why?
|
| Child | 1 | 2003 | 1420 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 177 | 0.040 |
Why?
|
| Spondylarthritis | 1 | 2017 | 3 | 0.040 |
Why?
|
| Cost Savings | 1 | 2017 | 36 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 50 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 352 | 0.030 |
Why?
|
| Sex Factors | 2 | 2012 | 476 | 0.030 |
Why?
|
| Adolescent | 1 | 2003 | 2307 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2017 | 154 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2015 | 27 | 0.030 |
Why?
|
| Orthopedics | 1 | 2017 | 113 | 0.030 |
Why?
|
| Joints | 1 | 2016 | 69 | 0.030 |
Why?
|
| Geography | 2 | 2005 | 18 | 0.030 |
Why?
|
| Patellar Ligament | 1 | 2015 | 42 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2014 | 62 | 0.030 |
Why?
|
| Operative Time | 1 | 2014 | 93 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2014 | 67 | 0.030 |
Why?
|
| Anthropometry | 1 | 2012 | 32 | 0.030 |
Why?
|
| California | 1 | 2012 | 32 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2012 | 17 | 0.020 |
Why?
|
| Fees and Charges | 1 | 2012 | 4 | 0.020 |
Why?
|
| Causality | 1 | 2011 | 56 | 0.020 |
Why?
|
| Wound Closure Techniques | 1 | 2011 | 5 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 737 | 0.020 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2011 | 32 | 0.020 |
Why?
|
| Arthralgia | 1 | 2012 | 125 | 0.020 |
Why?
|
| Acute Disease | 1 | 2011 | 208 | 0.020 |
Why?
|
| Body Size | 1 | 2010 | 13 | 0.020 |
Why?
|
| Educational Status | 1 | 2012 | 300 | 0.020 |
Why?
|
| Analgesia | 1 | 2010 | 37 | 0.020 |
Why?
|
| Age Factors | 1 | 2012 | 781 | 0.020 |
Why?
|
| Prognosis | 1 | 2012 | 825 | 0.020 |
Why?
|
| Accidental Falls | 1 | 2010 | 114 | 0.020 |
Why?
|
| Intraoperative Care | 1 | 2008 | 43 | 0.020 |
Why?
|
| Fracture Healing | 1 | 2008 | 34 | 0.020 |
Why?
|
| Connective Tissue | 1 | 2007 | 23 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 1143 | 0.020 |
Why?
|
| Materials Testing | 1 | 2007 | 136 | 0.020 |
Why?
|
| Research | 1 | 2006 | 43 | 0.020 |
Why?
|
| Medicare Part B | 1 | 2005 | 1 | 0.020 |
Why?
|
| Equipment Design | 1 | 2006 | 152 | 0.020 |
Why?
|
| Health Services for the Aged | 1 | 2005 | 10 | 0.020 |
Why?
|
| Walking | 1 | 2008 | 260 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 239 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2008 | 1384 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2003 | 110 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 356 | 0.010 |
Why?
|